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In contrast with medical tourism, which broadly describes the movement of individuals for non-
urgent and unnecessary treatments or recreational and leisure purposes such as cosmetic surgeries 
or spa visits (1), medical travel explicitly refers to patients crossing national borders with the purpose 
of receiving treatment that has been determined as essential to maintaining quality of life by a health 
professional, but may not need to be performed urgently (2). While medical travel offers potential 
economic gains as well as increased access to health care, it also poses notable risks to the well-being 
of the patient, which if disregarded could undermine the benefits that patients seek by traveling 
for medical care. We provide evidence that psychosocial factors such as stress, communication, 
and social support are integral to understanding the experiences of medical travelers and should 
be included in the evaluation of treatment outcomes and the development of policies regulating 
medical travel. We outline several key risks to well-being posed by medical travel, offer preliminary 
considerations for measuring well-being in outcome studies, and conclude with recommendations 
for incorporating well-being provisions into medical travel policies.
COnTEXT
With a significant number of people traveling abroad for medical care each year, there is a potential 
opportunity to control medical spending and increase access to health care by introducing patients 
to new locations with better quality care, lower costs, or reduced waiting times (2–4). Research 
has recently begun to establish relevant evidence and put forward considerations, which would 
support the development of medical travel policies that could help utilize this opportunity (5–7). 
However, this apparent increase in evidence is predominantly focused on medical or economic 
gains, and often fails to consider the potential impacts that medical travel might hold for health, 
beyond treating illness.
It is increasingly recognized by the international community that health and well-being are 
critical to developing, implementing, and evaluating policies (8–10). This approach, commonly 
referred to as Health in All Policies, recognizes that health extends beyond merely the absence of 
illness but rather refers to a state of physical, mental, and social well-being and thus lies outside 
of simple treatment (8). Accordingly, in response to the increasing numbers of medical travel-
ers, a global health access policy, which considers broader health implications and well-being, 
particularly in the evaluation of outcomes, may be required.
It has been well demonstrated that a lack of access to appropriate medical care may negatively 
affect health and well-being (11, 12). For example, a large study in a Chinese population showed 
that access to health care significantly increases the odds of healthy survival characterized by both 
high physical and mental well-being (13). The negative impact of poor access to health care on 
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well-being has been observed as particularly strong in developing 
countries but is also an issue for developed regions (14, 15). 
While high costs and poor quality are often barriers to health care 
in developing countries, among developed countries, sources of 
poor access tend to vary extensively (14, 15). There are major 
differences in perceived ability to afford care and receive the 
most effective care as well as disparities in waiting times (16). 
For instance, not being able to see a doctor due to inability to pay 
negatively affects well-being in the US, even for people with high 
income (17). Through improved utilization of available resources 
across the globe, medical travel can establish different pathways 
to increasing access to essential treatment.
However, medical travel creates myriad issues beyond those in 
traditional health-care settings that may impact well-being. These 
need to be considered before patients are advised to travel abroad 
for care and included in wider evaluations of such policies. 
Given that patients traveling abroad for medical care might be 
in a vulnerable position – ill, traveling to a potentially unfamiliar 
country or culture, possibly without social support – it is essential 
to identify the potential risks to medical travelers as well as ways 
to proactively ensure and promote their well-being at all stages 
of care. Many of these risks are potentially relevant to all medi-
cal travelers, even though some might be particularly pertinent 
to those patients that are traveling outside of their cultural and 
geopolitical regions or origins.
THREATS TO WELL-BEinG
Patients with illnesses or other disabling conditions are in an 
inherently stressful position. Such stress may be compounded if 
they are unfamiliar with hospital settings and events related to 
their treatment (18). However, when receiving treatment in their 
own country, policies and best practice guidelines that minimize 
distress are typically in place. For non-emergency interventions, 
the care pathway is typically structured, and patients are relatively 
prepared for the procedure. In most cases, they would have met 
their treatment provider, attended appointments, and be assured 
that their medical records are available to the treatment providers. 
The opportunity to have close relatives or friends with them in the 
treatment setting, as well as during rehabilitation and recovery, 
is likely available, and is an instrumental driver of successful 
recovery (19–23).
Given that medical travel is defined by the movement of 
patients across international borders, it is not surprising to find 
critical differences in the experience of acquiring medical treat-
ment at home or abroad. Such differences that existing policies 
in the treatment country cannot be expected to account for. 
However, medical travelers are often inadequately informed of 
the differences associated with receiving care abroad and pos-
sibly even presented with biased and incomplete information 
(24–26). Continuity of information has also been previously 
reported as a serious issue within cross-border care (26, 27). 
It is difficult for patients to anticipate their experience when 
traveling abroad for care: the clinicians, languages, locations, 
and potentially cultures can be unknown and unfamiliar (28). 
Sociocultural and language barriers between health-care profes-
sionals and patients can impair communication between parties, 
which predicts decreased patient satisfaction and negative treat-
ment outcomes (29–31). For example, a study of Latino patients 
in the US showed that language barriers might be a driver of 
patient dissatisfaction, lower quality of care, and poor health 
outcomes (32). Furthermore, the availability of social support is 
substantially diminished for medical travelers, while increased 
burden is placed on informal caregivers. During medical travel, 
the informal caregiver is required to fill various important roles 
encompassing facilitation of information flow between patients 
and health-care providers, provision of emotional and physical 
care, coordination of often complex medical travel, and contact 
between the patient and their broader social network in their 
home country (24).
These differences are of substantial importance when con-
sidering how well-being may be affected by engaging in medi-
cal travel. However, at present, approaches to the measurement 
of well-being in the context of medical travel are limited and 
inconsistent. In order for policy makers to make informed 
decisions about the inclusion of well-being in the development 
of a global health access policy, greater evidence needs to be 
established. To this end, psychology and other sciences can 
play an important role in developing adequate approaches 
to measuring well-being in the context of medical travel and 
establishing an evidence base to support its inclusion in a 
health access policy.
MEASUREMEnT
Within the context of medical travel, well-being should be 
measured in terms of its various facets (physical, subjective, 
and  social) using psychometrically valid instruments that 
are sensitive to change (33). This measurement ought to take 
place within a framework that focuses on individuals and their 
 support networks and could potentially expand to include the 
communities that are participating in medical travel. Through 
this, the impact of medical travel on well-being can be assessed, 
and further development and calibration of a health care access 
policy can be considered.
Evaluations of medical traveler outcomes are limited. To date, 
they focus mainly on patient satisfaction and clinical outcomes 
for select procedures or localities (7). Medical staff (34–36), 
facilities (36), support services (34, 35), and continuity of care 
(37) have been identified as some of the main determinants of 
patient satisfaction. Although limited in scope and design, evi-
dence from clinical outcome studies suggests that medical tour-
ists may be at increased risk for infection and microbial resistance 
(38–42), complications (43, 44), and mortality (45) compared 
with those who receive treatment locally. However, the available 
research on clinical outcomes lacks the systematic, randomized 
design that characterizes standard outcome studies and fails 
to provide follow-up data on patients after they return to their 
home countries (7). Moreover, although some research on patient 
satisfaction includes measures related to well-being such as the 
availability of support services, no attempts have been made to 
explicitly measure the psychosocial dimensions of medical travel 
alone or in relation to other outcomes.
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Assessing individual well-being before and during medical 
travel may allow for a more individualized approach toward 
patient needs and help direct resources in response to these 
needs. Of broader consequence, assessing change in patient 
well-being before and after medical travel could help to evalu-
ate the direct effects of the entire intervention. As such, there 
is considerable need for robust evidence using controlled trials 
to assess the long-term impact on health and well-being for 
those who received treatment abroad compared with those who 
received the same treatment in their own country, and those on 
long-term waitlists. It should also be emphasized that different 
instruments and methods may be required to assess short- and 
long-term changes (33).
Combining reliable and validated measures with more 
qualitative data gathering, such as feedback questionnaires and 
patient and carer interviews, will add further depth to policy 
discussions. It will allow policy makers and researchers to iden-
tify key issues related to well-being; aspects of the medical travel 
process that have greatest impact, either positive or negative, on 
the patient and their carers; and identify whether well-being is 
in fact a concern for a global policy on medical travel. This will 
facilitate the calibration of a more effective health access policy 
that is based on individual consequences and potentially societal 
impact.
RECOMMEnDATiOnS
Myriad arguments for and against medical travel are available, 
and the numbers of patients traveling abroad for medical treat-
ment appears to be increasing regardless (2). Currently, medical 
travel is subject to minimal regulation or standardization, and 
many of its limitations and risks go beyond those addressed in 
treatment countries’ existing policies and guidelines (6). This 
inevitably calls for a coherent global health access policy that 
ensures the adequate provision of care, and considers the impact 
of medical travel on the health and well-being of patients and 
other stakeholders.
Although there are certainly economic, legal, and quality 
considerations to be made when developing policies for medical 
travel in order to ensure as many benefits and little risks as pos-
sible, well-being should not be overlooked. Policy makers should 
consider the impact of a global health access on the well-being of 
individuals and communities.
In light of the principled debates related to medical travel, its 
potential pitfalls and benefits, we propose five preliminary but 
key recommendations from which to move forward:
 1. A global policy on medical travel should necessitate that 
quality information and communication are present during 
all stages of medical travel including decision-making, medi-
cal travel preparation, transportation, hospitalization, and 
follow-up care.
 2. A global health access policy should ensure that medical 
travelers are able to receive appropriate social support during 
travel. This should be delineated explicitly in the policy, and 
should clarify financial details for a companion.
 3. Respect for individual values will need to be aligned with 
existing international guidelines. This may require further 
consideration to ensure improved access does not require a 
tradeoff with cultural integrity.
 4. Well-being is infrequently and inconsistently measured in 
the context of medical travel. Adequate approaches to well-
being measurement should be developed in order to test the 
implications of a global policy on both short- and long-term 
health and well-being of medical travelers beyond immediate 
treatment outcomes.
 5. More systematic and comparative evidence on the effects of 
medical travel, perhaps through the application of controlled 
trials, is required.
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